Innovation Pharmaceuticals Inc (IPIX)

[dmattingly62]

Some idea of value and why we should see a steady climb to at least 3 over the coming weeks.

Trius- acquired for 704MM for a late stage compound, Tedizolid (complicated skin and skin-structure infections (cSSSI), including those caused by Methicillin-resistant Staphylococcus aureus (MRSA) that will replace Cubicin which faces generics by 2018

Durata- 220MM market cap, single late stage compound, dalbavancin ( abSSSI, MSRA)

Cempra- 293MM market cap, 1 late stage compound (bacterial pneumonia) and sodium fusidate (abSSSI, MSRA) phase 2

If we apply a reasonable discount to the above valuations we can expect to see CTIX at 3+ in the near future from Brilacidin alone.